Neuromodulation/Neurostimulation Device Development for Mental Health Applications
National Institutes of Health (NIH)
Total budget for direct costs: $275,000
Maximum request per year: $200,000
Total project period: 2 years
Encourage applications to develop next-generation brain stimulation devices for mental health disorders.
Transform the understanding and treatment of mental illnesses through research.
Multi-disciplinary teams including engineers, neuroscientists, and regulatory experts.
Individuals with mental health disorders who may benefit from innovative treatments.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local and state governments, and tribal governments.
Non-domestic entities (foreign organizations) are also eligible to apply.
Open to U.S. and non-domestic entities.
Foreign components of U.S. organizations are allowed.
Focus on developing novel brain stimulation devices or significantly enhancing existing FDA-approved devices.
Applications must be submitted by multi-disciplinary teams with expertise in relevant fields.
Combined budget for direct costs may not exceed $275,000.
No more than $200,000 may be requested in any single year.
Application due dates are set for various cycles, with the earliest submission date on January 16, 2025.
All applications are due by 5:00 PM local time of the applicant organization.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or overlapping applications under review at the same time.
Applications must include an Intellectual Property (IP) strategy.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise of the team.
Applications will undergo a peer review process by appropriate Scientific Review Groups.
Scientific and technical merit of the proposed project will be considered in funding decisions.
Applications must not propose clinical trials.
Focus on innovative approaches rather than incremental improvements.
Applications that do not meet the specified criteria will not be reviewed.
Encouragement of industry partnerships and collaborations.
High-risk, proof-of-concept applications are encouraged.
Multi-disciplinary collaboration is essential for success.
Avoid submitting applications that are not scientifically distinct.
Engage with industry partners to enhance project viability.
Focus on innovative and significant enhancements to existing technologies.